Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

3 High-Yielding Dividend Stocks That Are Near Their 52-Week Lows: https://g.foolcdn.com/editorial/images/747180/a-person-counting-money-in-their-living-room.jpg
3 High-Yielding Dividend Stocks That Are Near Their 52-Week Lows

Do you want to lock in a high-yielding dividend stock? You might consider those that are struggling and near their 52-week lows. While stock prices typically drop because of problems with the

Better Bull Market Buy: CRISPR vs. Medtronic Stock: https://g.foolcdn.com/editorial/images/747379/gettyimages-1172040755.jpg
Better Bull Market Buy: CRISPR vs. Medtronic Stock

The market hasn't yet entered bull territory, but it's getting close. The S&P 500 already rose more than 20% from its bear market low -- now, it just has to reach a new high, and the next bull

AEVIS VICTORIA SA – Publication of the half-year report 2023http://www.aevis.com: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/12720/aevis-logo.png
AEVIS VICTORIA SA – Publication of the half-year report 2023
AEVIS VICTORIA SA – Publication of the half-year report 2023
1 Tiny Stock That Could Be a Hidden Gem in the Coming Semiconductor Boom: https://g.foolcdn.com/editorial/images/746880/semiconductor-technician-with-wafer-in-manufacturing-plant.jpg
1 Tiny Stock That Could Be a Hidden Gem in the Coming Semiconductor Boom

Semiconductor manufacturing is receiving massive attention. The world needs more powerful and more power-efficient computing, and the transition to electrification (cars, the energy grid, etc.) is

3 Top Healthcare Stocks to Buy for September: https://g.foolcdn.com/editorial/images/746815/doctor-looking-at-camera-bookshelves.jpg
3 Top Healthcare Stocks to Buy for September

Healthcare is an evergreen frontier for investing. An endless need for better treatments and cures demands innovation and growth, which isn't a bad place to find long-term winners you can stick in a

Is the Worst Over for Illumina Stock?: https://g.foolcdn.com/editorial/images/746821/doctor-video-chatting-with-patients-while-working.jpg
Is the Worst Over for Illumina Stock?

With shares of the gene sequencing giant Illumina (NASDAQ: ILMN) collapsing by 53% over the last three years due to a combination of a botched acquisition attempt and weakness in its core business

This High-Yield Stock Is Cutting Its Dividend -- Here Is a Company That Won't: https://g.foolcdn.com/editorial/images/746162/physicians-in-an-operating-room.jpg
This High-Yield Stock Is Cutting Its Dividend -- Here Is a Company That Won't

Not all dividend stocks are created equal. Some haven't slashed their payouts in years and probably won't anytime soon, while others aren't so lucky. One dividend-paying company recently decided to

Why Shares of Neogen Are Slumping This Week: https://g.foolcdn.com/editorial/images/746964/a-scientist-uses-a-pipette-to-work-with-medical-samples.jpg
Why Shares of Neogen Are Slumping This Week

Shares of Neogen Corporation (NASDAQ: NEOG) were down more than 16% for the week, according to data provided by S&P Global Market Intelligence. The healthcare company, which specializes in food and

Why Insulet Stock Is Sinking Today: https://g.foolcdn.com/editorial/images/746894/insulin-pump.jpg
Why Insulet Stock Is Sinking Today

Shares of Insulet (NASDAQ: PODD) were sinking 9.3% as of 11:27 a.m. ET on Thursday after falling as much as 11.6% earlier in the session. The decline came as investors worried about the potential

EQS-News: SARTORIUS AG: Sartorius completes placement of bonds with a volume of 3 billion euros: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24067/Sartorius.svg.png
EQS-News: SARTORIUS AG: Sartorius completes placement of bonds with a volume of 3 billion euros
EQS-News: SARTORIUS AG: Sartorius completes placement of bonds with a volume of 3 billion euros
If You'd Invested $25,000 in CVS Health 20 Years Ago, This Is How Much You Would Have Today: https://g.foolcdn.com/editorial/images/746533/person-shopping-for-cough-medicine-in-a-pharmacy.jpg
If You'd Invested $25,000 in CVS Health 20 Years Ago, This Is How Much You Would Have Today

CVS Health (NYSE: CVS) has been selling health and beauty products since 1963. Over those six decades, the pharmacy operator and retailer built up a giant operation that now includes a pharmacy

EQS-Adhoc: GN Store Nord A/S: GN moves to “one company” governance structure; appoints Peter Karlstromer to Group CEO: https://mms.businesswire.com/media/20220816005068/en/1543852/5/GN_Logo_RGB_300ppi.jpg
EQS-Adhoc: GN Store Nord A/S: GN moves to “one company” governance structure; appoints Peter Karlstromer to Group CEO
EQS-Adhoc: GN Store Nord A/S: GN moves to “one company” governance structure; appoints Peter Karlstromer to Group CEO
Trupanion's Membership Is Soaring. Should You Buy the Stock?: https://g.foolcdn.com/editorial/images/745924/a-veterinarian-examines-a-cat.jpg
Trupanion's Membership Is Soaring. Should You Buy the Stock?

As a growth investor, few signs are as encouraging to witness from one of your holdings as a rapidly growing customer base. This is because such an occurrence typically means that the revenue of a

Down More Than 27% Last Month, Time to Buy This Marine Stock on the Dip?: https://g.foolcdn.com/editorial/images/745898/happy-friends-wine-boat-fun-wealth-rich-excited-water-ocean.jpg
Down More Than 27% Last Month, Time to Buy This Marine Stock on the Dip?

Despite a challenging selling environment, OneWater Marine (NASDAQ: ONEW) enjoyed a 4% revenue increase in its current fiscal year's third quarter, which ended June 30. This recreational boat dealer

3 Reasons ResMed's CEO Isn't Worried About Ozempic or Wegovy: https://g.foolcdn.com/editorial/images/746204/gettyimages-663845678.jpg
3 Reasons ResMed's CEO Isn't Worried About Ozempic or Wegovy

Every quarter, investors get excited for companies to report earnings. Some want the updated numbers that management teams share. Others are more curious to hear about plans and projections

Looking for Dividend Growth? Buy This Little-Known Healthcare Stock: https://g.foolcdn.com/editorial/images/746040/a-healthcare-professional-draws-blood-from-a-patient.jpg
Looking for Dividend Growth? Buy This Little-Known Healthcare Stock

If you consider yourself a dividend investor, asking yourself the following question may aid in your success: What separates the wheat from the chaff among dividend stocks? Such a question gets you

Is Medtronic Stock a Buy for Income Investors?: https://g.foolcdn.com/editorial/images/745760/a-doctor-takes-a-patients-blood-pressure.jpg
Is Medtronic Stock a Buy for Income Investors?

When constructing a stock portfolio oriented toward dividend growth, it is advisable to filter out all but the most proven companies as investments. One of the ways this can be done is to invest

LivaNova präsentiert Essenz In-Line Blood Monitor mit U.S. FDA 510(k)-Zulassung und CE-Prüfzeichen: https://mms.businesswire.com/media/20230830618951/de/1878567/5/LivaNova_Essenz_ILBM_image.jpg
LivaNova präsentiert Essenz In-Line Blood Monitor mit U.S. FDA 510(k)-Zulassung und CE-Prüfzeichen


LivaNova PLC (Nasdaq: LIVN), ein Marktführer im Bereich der Medizintechnik, gab heute bekannt, dass es die 510(k)-Zulassung der US-amerikanischen Food and Drug Administration (FDA) und das

Why Insulet Stock Rocked the Market Today: https://g.foolcdn.com/editorial/images/746062/medical-professionals-conferring-in-a-hospial-corridor.jpg
Why Insulet Stock Rocked the Market Today

Medical device maker Insulet's (NASDAQ: PODD) stock was the cure for the investor blues on Wednesday. Following news of a large insider buy, the shares subsequently shot more than 6% higher on the

LivaNova Unveils Essenz In-Line Blood Monitor with U.S. FDA 510(k) Clearance and CE Mark: https://mms.businesswire.com/media/20230830793488/en/1878567/5/LivaNova_Essenz_ILBM_image.jpg
LivaNova Unveils Essenz In-Line Blood Monitor with U.S. FDA 510(k) Clearance and CE Mark


LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance and CE Mark for its Essenz™ In-Line

Why Patterson Companies Stock Dropped Today: https://g.foolcdn.com/editorial/images/745983/veterinarian-cat-sick-pet-health.jpg
Why Patterson Companies Stock Dropped Today

Shares of Patterson Companies (NASDAQ: PDCO) fell as much as 14.2% early Wednesday, then partially recovered to trade down 5.6% as of 11.50 a.m. EDT after the company announced slightly

EQS-News: SARTORIUS AG: S&P Global Ratings assigns investment grade rating to Sartorius: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24067/Sartorius.svg.png
EQS-News: SARTORIUS AG: S&P Global Ratings assigns investment grade rating to Sartorius
EQS-News: SARTORIUS AG: S&P Global Ratings assigns investment grade rating to Sartorius
NanoString Appoints Todd Garland as Chief Commercial Officer: https://mms.businesswire.com/media/20230826560279/en/1875743/5/nanostring_headshot.jpg
NanoString Appoints Todd Garland as Chief Commercial Officer


NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for discovery and translational research, today announced that Todd Garland has been appointed Chief Commercial

Why Premier Stock Fell 16% This Week: https://g.foolcdn.com/editorial/images/745342/long-term-care-longterm-care-health-healthcare.jpg
Why Premier Stock Fell 16% This Week

Shares of Premier (NASDAQ: PINC) are down 15.5% this week as of 12:05 p.m. ET Friday, according to data provided by S&P Global Market Intelligence, after the healthcare-improvement leader announced

Is Medtronic Stock a Buy Now?: https://g.foolcdn.com/editorial/images/745044/two-people-working.jpeg
Is Medtronic Stock a Buy Now?

Companies that can withstand market volatility make for good long-term investments. Ireland-based Medtronic (NYSE: MDT), a major player in the medical device industry, has repeatedly demonstrated